Cargando…
Glucosamine protects against neuronal but not vascular damage in experimental diabetic retinopathy
OBJECTIVE: Glucosamine, an intermetabolite of the hexosamine biosynthesis pathway (HBP), is a widely used nutritional supplement in osteoarthritis patients, a subset of whom also suffer from diabetes. HBP is activated in diabetic retinopathy (DR). The aim of this study is to investigate the yet uncl...
Autores principales: | Eshwaran, Rachana, Kolibabka, Matthias, Poschet, Gernot, Jainta, Gregor, Zhao, Di, Teuma, Loic, Murillo, Katharina, Hammes, Hans-Peter, Schmidt, Martina, Wieland, Thomas, Feng, Yuxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479835/ https://www.ncbi.nlm.nih.gov/pubmed/34506973 http://dx.doi.org/10.1016/j.molmet.2021.101333 |
Ejemplares similares
-
Glucosamine inhibits extracellular matrix accumulation in experimental diabetic nephropathy
por: Teuma, Loic, et al.
Publicado: (2022) -
Involvement of NDPK-B in Glucose Metabolism-Mediated Endothelial Damage via Activation of the Hexosamine Biosynthesis Pathway and Suppression of O-GlcNAcase Activity
por: Chatterjee, Anupriya, et al.
Publicado: (2020) -
Role of the Ang2–Tie2 Axis in Vascular Damage Driven by High Glucose or Nucleoside Diphosphate Kinase B Deficiency
por: Chatterjee, Anupriya, et al.
Publicado: (2020) -
Contribution of the hexosamine biosynthetic pathway in the hyperglycemia-dependent and -independent breakdown of the retinal neurovascular unit
por: Wang, Yixin, et al.
Publicado: (2023) -
The effect of GLP-1 receptor agonist lixisenatide on experimental diabetic retinopathy
por: Oezer, Kuebra, et al.
Publicado: (2023)